| Literature DB >> 17060576 |
K Jin1, A Takeda, Y Shiga, S Sato, A Ohnuma, H Nomura, H Arai, S Kusunoki, M Ikeda, Y Itoyama.
Abstract
We measured the CSF tau protein levels in 26 patients with Guillain-Barré syndrome. The levels of the poor outcome group (Hughes grade at 6 months was between II and VI, n = 6) were higher than those of the good outcome group (0 or I, n = 20) (p < 0.0005). The higher levels of CSF tau may reflect axonal degeneration and could predict a poor clinical outcome in Guillain-Barré syndrome.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17060576 DOI： 10.1212/01.wnl.0000240119.29939.c7
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910